CClinicalTrials.gg
CompletedNCT07300605KT-AcuteStrokeUpdated Dec 24, 2025

Kinesio Taping for Upper Extremity Motor Function in Acute Stroke Patients

An interventional study of Kinesio Taping and Sham Taping in Acute Ischemic Stroke, Upper Extremity Hemiplegia and Kinesio Taping, sponsored by Koç University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 50 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-24.

Sponsored by Koç University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 7 years 5 months after the study started (first participant enrolled Jun 2018, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
50 Years to 80 Years
Sex
All
01

Study summary

This randomized, controlled clinical trial was conducted to evaluate the effects of kinesio taping on upper extremity motor recovery in patients with acute ischemic stroke who presented with flaccid muscle tone. Twenty-six adults were randomly assigned to either a kinesio taping group or a sham taping group, in addition to receiving standard rehabilitation. Participants were evaluated at baseline, at the end of the 3-week taping period, and at 6 weeks using validated measures of motor function, pain, general health, and depression. The study aimed to determine whether kinesio taping provides additional benefits beyond conventional rehabilitation in improving motor performance of the wrist and hand, reducing pain, and supporting overall functional and emotional well-being in the early phase of stroke recovery.

Read the detailed description

This prospective, randomized, controlled parallel-group trial investigated the clinical effects of kinesio taping on motor recovery of the upper extremity in patients with acute ischemic stroke. Participants were adults aged 50-80 years, within the first six months after stroke, presenting with Brunnstrom Stage 1 flaccid upper extremity and hand. Individuals with hemorrhagic stroke, prior upper limb surgery, severe shoulder pain, additional neurological conditions, or musculoskeletal complications affecting the upper limb were excluded. All participants received standard rehabilitation, including positioning training, conventional exercises, and splinting as needed.

Participants were randomized (1:1) into a kinesio taping group or a sham taping group. The kinesio taping protocol followed standard facilitation techniques applied to the dorsum of the hand and forearm with appropriate tension, aiming to support finger, wrist, and hand activation. Sham taping was performed without tension and without crossing joints, to avoid therapeutic effect while maintaining participant blinding. Both groups received three taping applications over approximately three weeks.

Outcome measures included Brunnstrom staging, Fugl-Meyer Assessment (upper extremity, wrist, and hand subscales), Visual Analog Scale for hand pain, Health Assessment Questionnaire, and Beck Depression Inventory. Evaluations were performed before treatment, at the end of the 3-week intervention period, and at 6 weeks. Statistical analyses were conducted using standard non-parametric methods for intra- and inter-group comparisons.

The study was designed to determine whether kinesio taping provides additional benefit beyond conventional rehabilitation in facilitating neurophysiological recovery, improving wrist and hand motor function, reducing pain, supporting functional independence, and decreasing depressive symptoms in the acute phase of stroke. No adverse events were observed during the study.

02

Conditions studied

  • Acute Ischemic Stroke
  • Upper Extremity Hemiplegia
  • Kinesio Taping

Browse trials for

Keywords

  • Kinesio Taping
  • Stroke Rehabilitation
  • Upper Extremity Recovery
  • Brunnstrom Stages
  • Fugl-Meyer Assessment
03

In context

Ischemic Stroke

2,593 studies on the registry are indexed under Ischemic Stroke; 930 are open to participants now.

This study's enrollment of 26 is below the median of 120 across 1,752 interventional studies indexed under Ischemic Stroke.

Browse Ischemic Stroke studies →

Lead sponsor

Koç University is the lead sponsor of 106 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults aged 50-80 years
  • Diagnosis of acute ischemic stroke confirmed by CT or MRI
  • Within first 6 months after stroke onset
  • Brunnstrom Stage 1 for upper extremity and hand (flaccid muscle tone)
  • Sufficient cognitive ability to follow instructions
  • Participation in inpatient or outpatient stroke rehabilitation
  • Ability to provide informed consent

Exclusion criteria

Exclusion Criteria:

  • Hemorrhagic stroke etiology
  • Prior upper extremity surgery, fracture, contracture, or heterotopic ossification
  • Brachial plexus injury or peripheral nerve lesions
  • Additional neurological disorders (e.g., Parkinson's disease, spinal cord injury, polyneuropathy)
  • Severe shoulder pain (VAS ≥ 5) that could interfere with assessments
  • Significant musculoskeletal disorders affecting the hemiplegic upper extremity
  • Uncontrolled comorbidities that prevent participation in rehabilitation
  • Inability to complete follow-up assessments
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    Kinesio Taping

    Participants received kinesio taping applied to the dorsum of the hand and forearm using standard facilitation techniques with approximately 25% tension, in addition to conventional rehabilitation.

    Other: Kinesio Taping

  • Sham comparator
    Sham Taping

    Participants received sham taping without tension and without crossing joints, mimicking the appearance of kinesio taping but without therapeutic effect, in addition to conventional rehabilitation.

    Other: Sham Taping

Interventions

  • OtherKinesio Taping

    Kinesio tape was applied to the dorsum of the hand with five 1-cm I-strips and one 5-cm I-strip extending toward the forearm, with \~25% stretch. Three applications over approximately 3 weeks.

  • OtherSham Taping

    Sham taping was performed using Y- and I-strips without stretch and without crossing joints. Three applications over approximately 3 weeks.

06

What researchers measure

Primary outcomes

  1. Change in Fugl-Meyer Wrist, Sitting Position Upper Extremity and Hand Scores

    Fugl Meyer Rating Scale (FMRS) was used to evaluate motor function. This scale was developed to evaluate the patient's sensorimotor recovery after stroke by the Brunnstrom motor healing stages. The scale covers the upper extremity in 3 parts: the shoulder-elbow-forearm, the sitting position in the wrist, the hand; and allows the evaluation of reflex activity, synergy patterns and voluntary movements. It is a reliable method for assessing the severity of post-stroke sensorimotor impairment. The maximum total score for the upper extremity in FMRS is 66.

    Time frame: Baseline, Week 3, Week 6

Secondary outcomes

  1. Change in Brunnstrom Staging (Upper Extremity and Hand)

    Combined assessment of upper extremity and hand motor recovery using the Brunnstrom Staging system (Stages 1-6). Higher stages indicate progressive neurophysiological motor recovery in the shoulder-elbow-forearm and hand components.

    Time frame: Baseline, Week 3, Week 6

  2. Change in Visual Analog Scale (VAS) for Hand Pain

    Pain intensity measured using a 10-cm visual analog scale (0 = no pain, 10 = worst pain). Lower scores indicate reduced hand pain.

    Time frame: Baseline, Week 3, Week 6

  3. Change in Health Assessment Questionnaire (HAQ) Disability Index

    Health Assessment Questionnaire (HAQ) was used for the general health evaluation of the patients. HAQ evaluates the functional ability of the patient in both upper and lower extremities. There are 20 questions in eight functionalities that represent a comprehensive range of functional activities, such as dressing, uplifting, eating, walking, hygiene, access, comprehension, and regular activities. The patient's responses are made on a scale from zero (unobstructed) to three (completely disabled).

    Time frame: Baseline, Week 3, Week 6

  4. Change in Beck Depression Inventory (BDI) Score

    Depressive symptoms measured by the Beck Depression Inventory (0-63). Lower scores indicate reduced depression severity.

    Time frame: Baseline, Week 3, Week 6

07

Study locations

1 site
  • SB Istanbul Education and Research Hospital
    Istanbul, Turkey (Türkiye)
08

References and documents

Study documents

  • Study protocol · Dec 1, 2025

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07300605
Lead sponsor
Koç University
Responsible party
Havvanur Albayrak (Specialist Physician, Department of Physical Medicine and Rehabilitation, SB Istanbul Education and Research Hospital) — Principal investigator
First posted
Dec 24, 2025
Start date
Jun 1, 2018
Primary completion
Sep 1, 2018
Completion
Nov 10, 2018
Last update
Dec 24, 2025

Study contacts

Havvanur Albayrak
principal investigator · Koç University School of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion